300
Participants
Start Date
June 30, 2007
Primary Completion Date
March 31, 2009
Study Completion Date
March 31, 2009
Etanercept , Methotrexate
"* Etanercept: 25 mg twice weekly over 16 weeks, SC~* Methotrexate: \> 7.5 mg/week and no more than 25 mg/week, PO"
Methotrexate; sulfasalazine; hydroxychloroquine;leflunomide
"* Methotrexate: at least 7.5 mg/wk and not more than 25 mg/wk.;PO~* Sulfasalazine: Start treatment w/500 mg daily for 1 wk, thereafter increase dose by 1 tab each wk to a max of 3 g/day;PO~* Hydroxychloroquine:400 mg daily in divided dose, may be reduced to 200 mg. Max: 6.5 mg/kg/day~* Leflunomide: Initially, loading dose 100 mg daily for 3 days. Maintenance: 20 mg daily"
Taipei
Taipei
Kaohsiung City
Manila
Manila
Quezon City
Makati City
Manila
Cebu
Bangkok
Pulau Pinang
Ipoh, Perak
Putrajaya
Kuala Lumpur
Seremban
New Delhi
Singapore
Hyderabaad
Bangalore
Bangalore
Hong Kong
Incheon
Seoul
Seoul
Seoul
Seoul
Seoul
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY